Turn Therapeutics TTRX
NASDAQ TTRX
$13.33 +0.02 (+0.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Turn Therapeutics (TTRX) Cash from Investing Activities (2024 - 2026)

Updated

Turn Therapeutics (TTRX) recorded Cash from Investing Activities of -$5,798 in Q2 2026.

Analysis

Turn Therapeutics (TTRX) Cash from Investing Activities (2024 - 2026) Analysis & Trends

On a TTM basis, Turn Therapeutics' Cash from Investing Activities came in at -$139,260 as of Jun 30, 2026; for FY2025, it came in at -$152,986.

  • Across earlier years, Cash from Investing Activities came in at -$99,475 in FY2024.
  • Per Business Quant, the preceding three quarters came in at -$12,227 (Q1 2026), -$31,441 (Q4 2025) and -$89,794 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Turn Therapeutics 397.07 Mn 397.07 Mn - -5,798.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5,798.00
Mar 31, 2026 -12,227.00
Dec 31, 2025 -31,441.00
Sep 30, 2025 -89,794.00
Dec 31, 2024 -7,842.00
API Access

Turn Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=TTRX&period=max&api_key=YOUR_API_KEY